IRIS
GIACOMETTI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.092
EU - Europa 8.682
AS - Asia 8.279
SA - Sud America 1.905
AF - Africa 452
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 13
Totale 36.440
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.794
SG - Singapore 2.697
VN - Vietnam 1.705
UA - Ucraina 1.494
RU - Federazione Russa 1.479
BR - Brasile 1.440
CN - Cina 1.302
IT - Italia 1.134
IE - Irlanda 827
DE - Germania 820
SE - Svezia 793
TR - Turchia 728
HK - Hong Kong 699
FR - Francia 582
DK - Danimarca 530
FI - Finlandia 405
KR - Corea 293
GB - Regno Unito 289
CI - Costa d'Avorio 202
IN - India 174
AR - Argentina 169
BD - Bangladesh 149
MX - Messico 125
CA - Canada 112
EC - Ecuador 82
JP - Giappone 72
ZA - Sudafrica 72
NL - Olanda 71
IQ - Iraq 67
ID - Indonesia 64
CO - Colombia 58
MA - Marocco 52
PL - Polonia 47
PK - Pakistan 46
VE - Venezuela 46
PY - Paraguay 37
UZ - Uzbekistan 35
AT - Austria 33
PH - Filippine 29
CL - Cile 28
ES - Italia 28
BE - Belgio 27
IR - Iran 27
MY - Malesia 24
TN - Tunisia 24
PE - Perù 21
EG - Egitto 20
KE - Kenya 20
NP - Nepal 19
SA - Arabia Saudita 19
RO - Romania 18
JO - Giordania 16
RS - Serbia 15
UY - Uruguay 15
AE - Emirati Arabi Uniti 14
DZ - Algeria 14
LT - Lituania 14
OM - Oman 14
CH - Svizzera 13
DO - Repubblica Dominicana 13
KZ - Kazakistan 13
BG - Bulgaria 12
AZ - Azerbaigian 11
EU - Europa 11
PS - Palestinian Territory 10
AU - Australia 9
IL - Israele 9
ET - Etiopia 8
HR - Croazia 8
PA - Panama 8
TT - Trinidad e Tobago 7
BO - Bolivia 6
CG - Congo 6
CZ - Repubblica Ceca 6
JM - Giamaica 6
SN - Senegal 6
TH - Thailandia 6
AL - Albania 5
CR - Costa Rica 5
CY - Cipro 5
KW - Kuwait 5
LB - Libano 5
SV - El Salvador 5
TW - Taiwan 5
GT - Guatemala 4
HN - Honduras 4
HU - Ungheria 4
MD - Moldavia 4
NI - Nicaragua 4
SY - Repubblica araba siriana 4
AO - Angola 3
BH - Bahrain 3
BY - Bielorussia 3
CM - Camerun 3
GE - Georgia 3
LY - Libia 3
NG - Nigeria 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
Totale 36.387
Salva come PNG Salva come JPEG
Città #
Ashburn 2.732
Singapore 1.628
Jacksonville 1.481
Chandler 1.165
Fairfield 1.116
Dallas 1.042
Dublin 818
Boardman 744
San Jose 726
Hong Kong 671
Wilmington 584
Ho Chi Minh City 539
Woodbridge 484
New York 453
Hanoi 438
Seattle 403
Houston 397
Des Moines 339
Ann Arbor 334
Cambridge 333
Beijing 329
Lawrence 314
Princeton 314
San Mateo 310
Moscow 294
Lauterbourg 278
The Dalles 270
Los Angeles 243
Abidjan 202
Hefei 190
San Diego 140
Centro 132
Munich 125
São Paulo 118
Turin 118
Milan 109
Buffalo 104
Da Nang 100
Orem 83
Council Bluffs 82
Helsinki 70
London 67
Redmond 66
Santa Clara 62
Turku 62
Chicago 60
Guangzhou 57
Tokyo 55
Haiphong 53
Shanghai 49
Ancona 47
Rio de Janeiro 46
Chennai 45
Miano 45
Norwalk 43
Izmir 41
Johannesburg 40
Mexico City 39
Montreal 36
Nuremberg 36
Warsaw 36
Tashkent 34
Denver 33
Rome 33
Belo Horizonte 32
Frankfurt am Main 32
Brooklyn 30
Columbus 30
Phoenix 30
Brasília 29
Washington 29
Wuhan 29
Guayaquil 28
Porto 28
Brussels 26
Biên Hòa 25
Dhaka 25
Manchester 25
Pune 25
Amsterdam 23
Atlanta 23
Hải Dương 23
Baghdad 22
Curitiba 22
Mumbai 22
Salt Lake City 22
Falls Church 21
Ninh Bình 21
Ottawa 21
Stockholm 21
Buenos Aires 20
Can Tho 20
Caracas 20
Poplar 20
Nanjing 19
Wuxi 19
Asunción 18
Boston 18
Elk Grove Village 18
Nairobi 18
Totale 22.291
Salva come PNG Salva come JPEG
Nome #
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 333
Antimicrobial Resistance: A Challenge for the Future 303
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 265
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 229
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 208
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. 207
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 200
Anticryptosporidial activity of paromomycin. 199
An (Italian) proposal for a comprehensive approach to infections across the surgical pathway 199
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 195
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. 189
ACTIVITY OF THE NEW ANTIFUNGAL TRIAZOLE, POSACONAZOLE, AGAINST CRYPTOCOCCUS NEOFORMANS 188
Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study 185
Characterization and clonal diffusion of ceftaroline non-susceptible mrsa in two hospitals in central Italy 184
Antimicrobial activity of polycationic peptides 182
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 182
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 181
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound 178
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 175
Ceftazidime-Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study 174
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 171
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 165
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 164
SARS-CoV-2 infection in kidney transplant recipients: Experience of the italian marche region 159
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection 158
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 157
Use of dalbavancin in skin, bone and joint infections: A real-life experience in an Italian center 156
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 154
Epidemiology and microbiology of surgical wound infections. 152
Effects of the Infusion of 4% or 20% Human Serum Albumin on the Skeletal Muscle Microcirculation in Endotoxemic Rats 150
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 150
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 148
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 148
In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds 148
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 147
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV. 147
[Prevalence of Toxocara spp in public playgrounds in a town of Central Italy] 146
[Giardiasis: a parasitic disease of continued topicality. Study of prevalence among a selected adult population] 146
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 146
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines. 146
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 146
In-vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity. 144
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 144
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 142
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 142
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 141
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 141
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 139
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 138
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 138
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 138
Efficacy of pexiganan combination with tigecycline in a mouse model of Pseudomonas aeruginosa sepsis 138
Tocilizumab in COVID-19 interstitial pneumonia 138
OC-34 Clinical outcome of switching to a dual drug regimen (2DR) vs. switching or remaining on a triple (3DR) regimen in the setting of a viral load ≤50 copies/mL 136
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp. 136
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 136
High rate of ceftobiprole resistance among clinical methicillin-resistant Staphylococcus aureus isolates from a hospital in central Italy 136
Clinical and microbiological features of ceftolozane/tazobactam-resistant Pseudomonas aeruginosa isolates in a university hospital in central Italy 133
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 133
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 132
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 132
Animal models commonly used to study quorum-sensing inhibitors. 132
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 132
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 131
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 131
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 131
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 131
Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy 131
whISOBAX™ inhibits bacterial pathogenesis and enhances the effect of antibiotics 131
Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis 130
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 130
Anticryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systems. 130
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 128
Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence 128
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 127
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 127
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 127
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 126
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 125
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 124
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 124
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin 124
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 123
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 123
Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. 122
Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. 122
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 122
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 122
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study 122
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50cp/mL. 122
Antiretroviral therapy management and rationalisation of available resources 122
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 121
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. 121
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. 120
A In vitro and in vivo activity of aurintricarboxylic acid against Cryptosporidium parvum 120
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 120
Efficacy of cathelicidin ll-37 in an mrsa wound infection mouse model 120
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 119
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 119
S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis. 119
Totale 14.996
Salva come PNG Salva come JPEG
Categoria #
all - tutte 167.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 167.561
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021229 0 0 0 0 0 0 0 0 0 0 0 229
2021/20222.517 215 539 25 123 34 174 124 149 167 297 193 477
2022/20233.933 409 368 294 271 284 624 7 206 1.023 20 303 124
2023/20242.292 430 45 137 379 406 470 34 63 21 25 37 245
2024/20254.916 646 419 288 131 165 238 447 190 1.102 304 441 545
2025/202614.025 758 1.131 1.178 1.625 1.273 860 2.496 1.418 1.312 1.158 311 505
Totale 36.890